Drug name - Vivitrol

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7919499 ALKERMES Naltrexone long acting formulations and methods of use Oct, 2029

(7 years from now)

Drugs and Companies using NALTREXONE ingredient

Treatment: Prevention of relapse to opioid dependence, following opioid detoxification; treatment of alcohol dependence

Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
380MG/VIAL FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.